HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephane De Wit Selected Research

Anti-HIV Agents (AIDS Drugs)

10/2019Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study.
8/2019Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study.
11/2017Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
1/2016An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.
10/2012Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
10/2010Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.
2/2010Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.
3/2009Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.
2/2009Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephane De Wit Research Topics

Disease

9Cardiovascular Diseases (Cardiovascular Disease)
11/2017 - 03/2009
8Acquired Immunodeficiency Syndrome (AIDS)
11/2021 - 01/2011
7Infections
05/2022 - 08/2006
7Myocardial Infarction
01/2013 - 11/2003
5Lipodystrophy
04/2022 - 01/2005
4Insulin Resistance
12/2021 - 06/2008
4Hypertension (High Blood Pressure)
11/2021 - 01/2005
4HIV Infections (HIV Infection)
11/2015 - 10/2008
3Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2022 - 03/2009
3Chronic Renal Insufficiency
10/2019 - 07/2010
3Hepatitis B
12/2014 - 10/2008
2Body Weight (Weight, Body)
05/2022 - 07/2010
2Weight Gain
12/2021 - 11/2021
2Inflammation (Inflammations)
12/2021 - 01/2011
2Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2021 - 09/2010
2Stroke (Strokes)
08/2019 - 01/2013
2Coinfection
12/2014 - 04/2012
2Diabetes Mellitus
10/2012 - 02/2009
2Dyslipidemias (Dyslipidemia)
10/2012 - 04/2007
2Coronary Disease (Coronary Heart Disease)
02/2009 - 04/2008
1Thrombophilia
12/2021
1Heart Failure
12/2021
1Shock
01/2019
1Fibrosis (Cirrhosis)
01/2019
1Drug Hypersensitivity Syndrome
01/2018
1Overweight
10/2016
1Osteoporosis
11/2015
1Metabolic Bone Diseases (Osteopenia)
11/2015
1Hypersensitivity (Allergy)
01/2015
1Type 2 Diabetes Mellitus (MODY)
12/2014
1Prostatic Neoplasms (Prostate Cancer)
01/2014
1Neoplasms (Cancer)
10/2013
1Lung Neoplasms (Lung Cancer)
10/2013
1Hypercholesterolemia
07/2013
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2013
1Duodenal Ulcer (Curling's Ulcer)
04/2012
1Thrombosis (Thrombus)
10/2008
1Liver Diseases (Liver Disease)
08/2006

Drug/Important Bio-Agent (IBA)

9Anti-HIV Agents (AIDS Drugs)IBA
10/2019 - 02/2009
9Pharmaceutical PreparationsIBA
01/2016 - 08/2006
5LipidsIBA
05/2022 - 04/2007
4CholesterolIBA
10/2016 - 11/2003
4abacavir (Ziagen)FDA Link
11/2015 - 04/2008
3Biomarkers (Surrogate Marker)IBA
12/2021 - 10/2008
3Raltegravir PotassiumFDA Link
11/2021 - 11/2015
3RNA (Ribonucleic Acid)IBA
01/2021 - 10/2008
3Protease Inhibitors (Protease Inhibitor)IBA
10/2019 - 01/2005
3Triglycerides (Triacylglycerol)IBA
07/2011 - 11/2003
3Reverse Transcriptase InhibitorsIBA
04/2008 - 01/2005
2tenofovir alafenamideIBA
11/2021 - 11/2015
2dolutegravirIBA
11/2021 - 01/2018
2CreatinineIBA
11/2015 - 07/2010
2HDL CholesterolIBA
07/2011 - 03/2009
2NucleosidesIBA
04/2008 - 01/2005
1drug combination tenofovir alafenamide emtricitabine bictegravirIBA
05/2022
1EnzymesIBA
04/2022
1Lipopolysaccharide ReceptorsIBA
12/2021
1AdiponectinIBA
12/2021
1Hepatitis B e AntigensIBA
12/2019
1Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2019
1Alanine Transaminase (SGPT)IBA
01/2019
1Transaminases (Aminotransferases)IBA
01/2019
1Serum AlbuminIBA
01/2018
1SteroidsIBA
11/2015
1Surface Antigens (Surface Antigen)IBA
11/2015
1Tenofovir (Viread)FDA Link
11/2015
1HLA-B57 antigenIBA
01/2015
1C-Reactive ProteinIBA
12/2014
1Interleukin-6 (Interleukin 6)IBA
12/2014
1Prostate-Specific Antigen (Semenogelase)IBA
01/2014
1N-acetoacetyl-N-deacetylcolchicineIBA
10/2013
1LopinavirFDA Link
07/2013
1Ritonavir (Norvir)FDA Link
01/2013
1Atazanavir Sulfate (Reyataz)FDA Link
01/2013
1MacrolidesIBA
04/2012
1Anti-Bacterial Agents (Antibiotics)IBA
04/2012
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2012
1Proton Pump InhibitorsIBA
04/2012
1insulin receptor-related receptor (IRR)IBA
01/2011
1fibrin fragment D (D-dimer)IBA
01/2011
1Thromboplastin (Tissue Factor)IBA
10/2008
1ThymidineIBA
06/2008
1Didanosine (Videx)FDA LinkGeneric
04/2008
1Zidovudine (Retrovir)FDA LinkGeneric
04/2008
1Stavudine (Zerit)FDA LinkGeneric
04/2008
1Lamivudine (Epivir)FDA Link
04/2008
1Antihypertensive Agents (Antihypertensives)IBA
01/2005

Therapy/Procedure

9Therapeutics
11/2021 - 10/2008
6Highly Active Antiretroviral Therapy (HAART)
10/2012 - 11/2003
5Art Therapy
01/2021 - 01/2011
1Ambulatory Care (Outpatient Care)
01/2013